FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3

• Xingchen Dong,
• Chunmiao Cai,
• Ting Fu

Affiliations

Xingchen Dong

Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wisconsin–Madison, Madison, WI 53705, USA

Chunmiao Cai

Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wisconsin–Madison, Madison, WI 53705, USA

Ting Fu

Corresponding author. Pharmaceutical Sciences Division, University of Wisconsin–Madison, 777 Highland Ave, Madison, WI 53705, USA.; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wisconsin–Madison, Madison, WI 53705, USA